“Broken heart syndrome” can mimic a heart attack so closely that patients often need invasive testing to tell the difference. Researchers have now developed the BioTAK score, which combines biological sex with blood biomarkers to identify the condition before cardiac catheterization. In a validation study of nearly 1,800 patients, it correctly classified almost 90% of participants.
New Test Distinguishes 'Broken Heart Syndrome' from Heart Attacks
Researchers have developed the BioTAK score to differentiate between 'broken heart syndrome' and heart attacks, which is crucial for accurate diagnosis and treatment. This advancement could improve healthcare outcomes in Iran, where cardiovascular diseases are prevalent. The study involved nearly 1,800 patients and achieved a high accuracy rate.
👥 Key Players
📰 What Happened
Researchers have created the BioTAK score, a new diagnostic tool that distinguishes 'broken heart syndrome' from heart attacks, potentially reducing unnecessary invasive procedures. In a study of nearly 1,800 patients, it achieved a classification accuracy of almost 90%.
- The BioTAK score combines biological sex and blood biomarkers for diagnosis.
- The study involved a significant sample size of nearly 1,800 patients.
💡 Why It Matters
📚 Background
Broken heart syndrome, or stress-induced cardiomyopathy, mimics heart attack symptoms, complicating diagnosis. Accurate differentiation is crucial for effective treatment.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%